Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.10% | 14.53% | -15.68% | -18.71% | 17.38% |
| Total Depreciation and Amortization | -100.00% | 0.00% | 0.00% | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,918.18% | -97.65% | 212.00% | -26.11% | -53.86% |
| Change in Net Operating Assets | 116.67% | 205.36% | -42.86% | 790.91% | -95.54% |
| Cash from Operations | 24.00% | 10.46% | -10.03% | -15.80% | -3.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -39.29% | -- | 100.00% | -56.44% | 33.55% |
| Issuance of Common Stock | -- | -100.00% | 60.25% | 14,623.53% | -99.02% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -76.47% | 83.41% | -27.73% | -542.00% | -233.33% |
| Cash from Financing | 2,412.22% | -105.03% | 76.68% | 1,610.45% | -108.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 153.76% | -4,402.60% | 106.66% | 59.86% | -163.98% |